The global pharmaceutical industry is led by giants that have established near-monopolistic control, dictating market trends and influencing drug availability worldwide. This dominance has often stifled innovation and limited competition, creating a challenging environment for new market entrants.
However, emerging pharmaceutical companies are exploring alternative models to drive faster innovation. It signifies a need for new systems that address unmet medical needs and drive…
Read More…
Entrepreneurial evolution: Redefining business models at the forefront of pharmaceutical Innovation
